Provided by Tiger Trade Technology Pte. Ltd.

Onconetix Inc.

1.02
+0.281038.02%
Pre-market: 0.8323-0.1877-18.40%09:08 EDT
Volume:6.66M
Turnover:6.27M
Market Cap:4.03M
PE:-0.38
High:1.05
Open:0.7385
Low:0.7106
Close:0.7390
52wk High:209.50
52wk Low:0.5868
Shares:3.95M
Float Shares:3.69M
Volume Ratio:43.84
T/O Rate:180.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6880
EPS(LYR):-828.1488
ROE:-105.23%
ROA:-27.03%
PB:0.30
PE(LYR):0.00

Loading ...

Onconetix Inc - Appoints Sammy Dorf as Chairman of the Board Effective April 23, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 25

HRT Financial disposes of Onconetix common shares worth $111,832

Reuters
·
Apr 22

HRT Financial acquires $126,694 of Onconetix common shares

Reuters
·
Apr 17

Onconetix files Form 3 as HRT Financial LP reports beneficial ownership

Reuters
·
Apr 17

Onconetix says Realbotix acquisition expected to close in second half of 2026

Reuters
·
Apr 09

Onconetix says Realbotix expects delivery of 19 robots as acquisition pending

Reuters
·
Apr 02

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

THOMSON REUTERS
·
Apr 02

Onconetix names David White CEO as it pursues Realbotix acquisition

Reuters
·
Apr 01

BRIEF-Onconetix Appoints David White As Chief Executive Officer And Sammy Dorf As Member Of The Board Of Directors

Reuters
·
Mar 31

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

THOMSON REUTERS
·
Mar 31

Onconetix Inc - Karina Fedasz to Continue as Interim CFO at Onconetix

THOMSON REUTERS
·
Mar 31

Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push

TIPRANKS
·
Mar 31

Onconetix files initial beneficial ownership statement; CEO David Allan White reports no securities beneficially owned

Reuters
·
Mar 28

Onconetix files Form 3 initial beneficial ownership statement; director Sammy Dorf reports no securities beneficially owned

Reuters
·
Mar 28

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:16 AM

Reuters
·
Mar 27

Why Is Onconetix Stock (ONCO) Up Today?

TIPRANKS
·
Mar 27

What's Going On With Onconetix Shares On Friday?

Benzinga
·
Mar 27

Onconetix approves 1-for-5 reverse stock split; outstanding shares drop to about 0.7 million

Reuters
·
Mar 27

Onconetix highlights Proclarix prostate cancer test; acquisition of Realbotix expected to close in H2 2026

Reuters
·
Mar 26

Onconetix files 8-K/A; White employment agreement appears as Exhibit 10.1 due to processing error

Reuters
·
Mar 26